© 2021 MJH Life Sciences and Patient Care Online. All rights reserved.
© 2021 MJH Life Sciences™ and Patient Care Online. All rights reserved.
J H Carter-Lourensz MD
June 02, 2017
Here, in plain language, a list of the most common questions you may hear about HCV and the answers, in brief.
Every patient encounter is an opportunity to screen for hepatitis C. Certain women of childbearing age must be included as an at-risk population.
May 01, 2017
Eight studies at the 2017 International Liver Congress illuminate the question but the answer is open to interpretation.
April 24, 2017
Take this brief quiz to see what you’ve learned about the challenges and opportunities of HCV management.
Resistance-associated variants limit the activity of some drugs, but HIV infection treatment may offer some guidance.
April 18, 2017
Severe outcomes may ensue in a high percentage of patients. The authors discuss the consequences in this brief podcast.
April 17, 2017
The “modern era” of treatment features multiple DAAs that target specific steps within the HCV life cycle.
April 10, 2017
State Medicaid programs and private insurance companies have balked at providing these drugs to their insured customers. But the tide is turning.
Testing is recommended for the persons who are more likely to have the virus but not know it.
April 06, 2017
Test your knowledge of screening and HCV management with these three short case quizzes.